Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study

Stefan Sack, Christian Michael Wende, Herbert Nägele, Amos Katz, Wolfgang Rudolf Bauer, Craig Scott Barr, Klaus Malinowski, Harald Schwacke, Francisco Leyva, Jochen Proff, Sergey Berdyshev, Vincent Paul, Stefan Sack, Christian Michael Wende, Herbert Nägele, Amos Katz, Wolfgang Rudolf Bauer, Craig Scott Barr, Klaus Malinowski, Harald Schwacke, Francisco Leyva, Jochen Proff, Sergey Berdyshev, Vincent Paul

Abstract

Aim: To investigate whether diagnostic data from implanted cardiac resynchronization therapy defibrillators (CRT-Ds) retrieved automatically at 24 h intervals via a Home Monitoring function can enable dynamic prediction of cardiovascular hospitalization and death.

Methods and results: Three hundred and seventy-seven heart failure patients received CRT-Ds with Home Monitoring option. Data on all deaths and hospitalizations due to cardiovascular reasons and Home Monitoring data were collected prospectively during 1-year follow-up to develop a predictive algorithm with a predefined specificity of 99.5%. Seven parameters were included in the algorithm: mean heart rate over 24 h, heart rate at rest, patient activity, frequency of ventricular extrasystoles, atrial-atrial intervals (heart rate variability), right ventricular pacing impedance, and painless shock impedance. The algorithm was developed using a 25-day monitoring window ending 3 days before hospitalization or death. While the retrospective sensitivities of the individual parameters ranged from 23.6 to 50.0%, the combination of all parameters was 65.4% sensitive in detecting cardiovascular hospitalizations and deaths with 99.5% specificity (corresponding to 1.83 false-positive detections per patient-year of follow-up). The estimated relative risk of an event was 7.15-fold higher after a positive predictor finding than after a negative predictor finding.

Conclusion: We developed an automated algorithm for dynamic prediction of cardiovascular events in patients treated with CRT-D devices capable of daily transmission of their diagnostic data via Home Monitoring. This tool may increase patients' quality of life and reduce morbidity, mortality, and health economic burden, it now warrants prospective studies. ClinicalTrials.gov NCT00376116.

Figures

Figure 1
Figure 1
Sensitivity values for the basic five-parameter predictor (A) and for the enhanced seven-parameter predictor (B), to detect major cardiovascular events from Table 3. In (A), combinations of two, three, and four parameters were made by adding the next best individual parameter. (B) shows the sensitivities for two new parameters and for the combination of all seven parameters. The combination of the two new parameters from (B) without ‘help’ of parameters from (A) had still suboptimal sensitivity of 50% (not shown). All sensitivity values were calculated retrospectively for the target specificity of 99.5%.
Figure 2
Figure 2
Modified receiver operating characteristic curve for the enhanced seven-parameter predictor. Plots show the trade-off between sensitivity to detect impending cardiovascular hospitalization or death and the number of false-positive detections per patient-year of monitoring, as a function of varying thresholds for weighted trends. The optimal point is indicated by the circle.
Figure 3
Figure 3
Example of parameter trends and the resulting combined predictor line (upper panel) in a patient hospitalized for heart failure worsening on 5 April 2008. The seven-parameter predictor reached threshold (beginning of the grey area) 16 days before hospitalization. The threshold was set at 200 arbitrary units as a result of the algorithm optimization process described in the section Methods, and corresponds to a hazard ratio of 7.15. ActP, patient activity; a.u., arbitrary units; bpm, beats per minute; MHR24, mean heart rate during 24 h; MHRR, heart rate at rest; PPVar P–P interval variability; PSHImp, painless shock impedance; RVImp, right ventricular impedance; VES, ventricular extrasystoles; WHF, worsening heart failure.

References

    1. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ. 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur J Heart Fail. 2010;12:1143–1153.
    1. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Klein W, Tavazzi L. Baseline characteristics of patients recruited into the CARE-HF study. Eur J Heart Fail. 2005;7:205–214.
    1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150.
    1. Bruch C, Bruch C, Sindermann J, Breithardt G, Gradaus R. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator. Europace. 2007;9:681–686.
    1. Catanzariti D, Lunati M, Landolina M, Zanotto G, Lonardi G, Iacopino S, Oliva F, Perego GB, Varbaro A, Denaro A, Valsecchi S, Vergara G. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol. 2009;32:363–370.
    1. Small RS, Wickemeyer W, Germany R, Hoppe B, Andrulli J, Brady PA, Labeau M, Koehler J, Sarkar S, Hettrick DA, Tang WH. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. 2009;15:475–481.
    1. Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol. 2010;55:1803–1810.
    1. Abraham WT. New approaches to monitoring heart failure before symptoms appear. Rev Cardiovasc Med. 2006;7(Suppl 1):S33–S41.
    1. Burri H, Senouf D. Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators. Europace. 2009;11:701–709.
    1. Varma N, Epstein AE, Irimpen A, Schweikert R, Love C. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010;122:325–332.
    1. Boriani G, Diemberger I, Martignani C, Biffi M, Valzania C, Bertini M, Domenichini G, Saporito D, Ziacchi M, Branzi A. Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. J Gen Intern Med. 2008;23(Suppl 1):73–77.
    1. Small RS. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic. Am J Cardiol. 2007;99(10A):17G–22G.
    1. Vollmann D, Nagele H, Schauerte P, Wiegand U, Butter C, Zanotto G, Quesada A, Guthmann A, Hill MR, Lamp B. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. 2007;28:1835–1840.
    1. Wang L. Fundamentals of intrathoracic impedance monitoring in heart failure. Am J Cardiol. 2007;99(10A):3G–10G.
    1. Ypenburg C, Bax JJ, van der Wall EE, Schalij MJ, van EL. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol. 2007;99:554–557.
    1. Stambler BS, Ellenbogen KA, Liu Z, Levine P, Porter TR, Zhang X. Serial changes in right ventricular apical pacing lead impedance predict changes in left ventricular ejection fraction and functional class in heart failure patients. Pacing Clin Electrophysiol. 2005;28(Suppl 1):S50–S53.
    1. Matsushita K, Ishikawa T, Sumita S, Kobayashi T, Ogawa H, Inoue N, Matsumoto K, Taima M, Nakazawa I, Sugano T, Ishigami T, Uchino K, Umemura S. Daily shock impedance measured by implantable cardioverter defibrillator is useful in the management of congestive heart failure. Circ J. 2006;70:1462–1465.
    1. Maines M, Landolina M, Lunati M, Lonardi G, Pappone A, Proclemer A, Zanotto G, Santini M, Varbaro A, Vimercati M, Valsecchi S. Intrathoracic and ventricular impedances are associated with changes in ventricular volume in patients receiving defibrillators for CRT. Pacing Clin Electrophysiol. 2010;33:64–73.
    1. Adamson PB, Smith AL, Abraham WT, Kleckner KJ, Stadler RW, Shih A, Rhodes MM. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation. 2004;110:2389–2394.
    1. Fung JW, Yu CM. Implantable cardiac resynchronization therapy devices to monitor heart failure clinical status. Curr Heart Fail Rep. 2007;4:48–52.
    1. Germany R, Murray C. Use of device diagnostics in the outpatient management of heart failure. Am J Cardiol. 2007;99(10A):11G–6G.
    1. Perego GB, Landolina M, Vergara G, Lunati M, Zanotto G, Pappone A, Lonardi G, Speca G, Iacopino S, Varbaro A, Sarkar S, Hettrick DA, Denaro A. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. J Interv Card Electrophysiol. 2008;23:235–242.
    1. Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ, Stamler J. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol. 1999;149:853–862.
    1. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50:823–830.
    1. Soliman EZ, Elsalam MA, Li Y. The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording. Europace. 2010;12:261–265.
    1. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Frederiksen BS, Davanlou M, Hansen JF. Ventricular arrhythmias and risk of death and acute myocardial infarction in apparently healthy subjects of age ≥55 years. Am J Cardiol. 2006;97:1351–1357.
    1. Boveda S, Marijon E, Jacob S, Defaye P, Winter JB, Bulava A, Gras D, Albenque JP, Combes N, Pavin D, Delarche N, Teubl A, Lambiez M, Chevalier P. Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study. Eur Heart J. 2009;30:1237–1244.
    1. Szabo BM, van Veldhuisen DJ, Crijns HJ, Wiesfeld AC, Hillege HL, Lie KI. Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure. Eur Heart J. 1994;15:928–933.
    1. Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol. 2009;53:355–360.
    1. Page E, Cazeau S, Ritter P, Galley D, Casset C. Physiological approach to monitor patients in congestive heart failure: application of a new implantable device-based system to monitor daily life activity and ventilation. Europace. 2007;9:687–693.
    1. Adamson PB, Magalski A, Braunschweig F, Bohm M, Reynolds D, Steinhaus D, Luby A, Linde C, Ryden L, Cremers B, Takle T, Bennett T. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003;41:565–571.
    1. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM, Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51:1073–1079.
    1. Ellery S, Pakrashi T, Paul V, Sack S. Predicting mortality and rehospitalization in heart failure patients with Home Monitoring: the Home CARE pilot study. Clin Res Cardiol. 2006;95(Suppl 3):iii29–iii35.
    1. Powell MJD. An efficient method for finding the minimum of a function of several variables without calculating derivatives. Comput J. 1964;7:152–162.
    1. Braunschweig F, Ford I, Conraads V, Cowie MR, Jondeau G, Kautzner J, Lunati M, Munoz AR, Yu CM, Marijianowski M, Borggrefe M, van Veldhuisen DJ. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF) Eur J Heart Fail. 2008;10:907–916.
    1. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J. The European cardiac resynchronization therapy survey. Eur Heart J. 2009;30:2450–2460.
    1. van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, Swedberg K. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail. 2009;11:1143–1151.

Source: PubMed

3
구독하다